United States: After the Federal Circuit IEEPA tariff ruling, what comes next?

In brief

On August 29, 2025, the US Court of Appeals for the Federal Circuit (CAFC) issued a 7-4 en banc opinion in VOS Selections, Inc. v. Trump, holding that the International Emergency Economic Powers Act (IEEPA) does not authorize the President to impose broad, indefinite tariffs. The case was initially brought in the Court of International Trade (CIT) by private businesses and the US state attorneys general. The President invoked IEEPA on various grounds, including concerns about drug enforcement, border security, and trade deficits. In a May decision granting summary judgment to the VOS Selections plaintiffs, the CIT found that IEEPA does not authorize the President to impose the tariffs at issue, which the US Government appealed.


Impact on trade negotiations

The ruling casts uncertainty over the Administration's use of tariffs as leverage in trade discussions. Since the imposition of the IEEPA tariffs, the Administration has announced bilateral agreements with certain trading partners, including the European Union, the United Kingdom, and Japan, while imposing new tariffs on dozens of others. The President has commented that restrictions on the use of IEEPA tariffs could compromise the Administration's leverage in trade negotiations and force the US to "unwind" trade deals it has already struck.

Background

IEEPA tariffs remain in place, for now

While the CAFC decision struck down the Administration's "reciprocal" and "fentanyl" tariffs, the CAFC vacated the injunction issued by the CIT and remanded the case back for further consideration of injunctive relief in light of the Supreme Court's decision in Trump v. CASA. The tariffs remain in effect until October 14, 2025, to give the Administration time to seek Supreme Court review.

A number of other lawsuits challenging the IEEPA tariffs have already been filed, adding another layer of complexity. In Learning Resources, Inc., et al v. Donald Trump, et al, the District Court for the District of Columbia ruled in May that IEEPA does not confer any tariff authority at all. This goes further than the CIT and CAFC decisions that IEEPA does not authorize the tariffs at issue. The US Government has appealed the ruling and the plaintiffs have sought immediate Supreme Court review of the decision. The Supreme Court is expected to decide whether to take the case when it reconvenes in late September. A number of other cases filed challenged the IEEPA tariffs, but these have been stayed pending resolution of certain jurisdictional questions at play in VOS Selections and Learning Resources.

On a fast track in the Supreme Court

On September 9, 2025, the Supreme Court granted certiorari to hear the case, reacting to the Administration’s September 3, 2025, petition to review the CAFC decision on an expedited basis. Oral argument is set for early November.

What comes next?

If IEEPA is deemed to be improper support for the reciprocal and fentanyl tariffs, the Administration has hinted that it may pivot to other statutory authorities to buttress its trade agenda, including Section 301 of the Trade Act of 1974 (which authorizes tariffs after investigation of unfair trade practices), and Section 232 of the Trade Expansion Act of 1962 (which authorizes tariffs for national security purposes and has already been invoked for steel and aluminum tariffs). The current Administration has already imposed tariffs under Section 232 on steel, aluminum, automobiles and auto parts, and copper, and announced Section 232 investigations on lumber and paper products, pharmaceutical products, semiconductors, and more, and recently initiated a Section 301 investigation on certain practices in Brazil.

Over the coming months, it will be essential for businesses to remain apprised of developments and be prepared to adjust their sourcing and supply chain arrangements to reflect changes in the law. Importers should be monitoring their imports for which IEEPA tariffs were paid and closely reviewing liquidation dates to ensure that they do not potentially lose the ability to claim refunds. 

Stay up to date on the latest developments in customs programs, trade remedies, and global trade policy by subscribing to our Import and Trade Remedies Blog.


Copyright © 2025 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.